Skip to content
DraconiticResearch
Search Sources API
210,089 studies31 sourcesUpdated 15 min ago

Oncology

5,305 studies560 in 7 days2,549 in 30 days

Filters
Type
Date
Clear

Latest

5,305 studies

  1. MYC drives endothelial transformation and dedifferentiation in angiosarcoma
    C. K. Wong, D. Li, T. Itkin +19
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  2. Tumour-stroma signaling drives a reversible program with neural-like features in cancer-associated fibroblasts
    M. I. Ibanez-Rios, M. Batardiere, E. Dianati +7
    bioRxivPreprintCC BYFull textOncologybioRxiv
  3. Regional reproducibility of immune expression programs in glioblastoma and implications for single-biopsy assessment
    C. K. Goldman
    bioRxivPreprintCC BY-NCFull textOncologybioRxiv
  4. Pdk1-dependent metabolic heterogeneity promotes aggressive colorectal cancer through cell-intrinsic interferon signaling
    J. Calviello, L. Poeltl, A. Mira +17
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  5. Artificial Intelligence Applied to Epigenomic Data in Leukemia: A Systematic Review of Diagnostic, Prognostic and Monitoring Models
    J. Martelli, J. Martelli
    bioRxivPreprintCC0Full textOncologybioRxiv
  6. Epstein-Barr virus co-opts ADAR1 to evade PKR activation of the integrated stress response in nasopharyngeal carcinoma
    S. Wiebe, M. G. Ng, A. Roslan +2
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  7. Mathematical Modelling of Stochastic Gene Expression Quantifies mRNA Heterogeneity in Cancer Cell Populations with Extrachromosomal DNA
    P. S. Ganguly, W. Huang
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  8. Coordinated alterations in SWI/SNF chromatin remodeling complex, mRNA splicing and mRNA methylation as hallmarks of salivary gland adenoid cystic carcinoma (SACC)
    K. Stawarz, N. Rusetska, H. Salamaga +18
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  9. Inhibitory Nectin-2/TIGIT interactions between CD163+ macrophages and CD8+ T cells in spatially defined immune niches associate with poor outcomes in neuroblastoma
    A. L. Borst, F. J. Bergsma, F. van den Ham +12
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  10. Illness Meaning-Making in an Oncology Support Group: A Longitudinal Lexical Correspondence Analysis of Group Discourse.
    Claudia Venuleo, Paolo Colavero, Silvia De Padova +1
    European journal of investigation in health, psychology and educationPeer-reviewedCC BYFull textOncologyEurope PMC
  11. Patient-Reported Burden and Clinical Spectrum of Rheumatic Immune-Related Adverse Events After Immune Checkpoint Inhibitor Therapy in Lung Cancer: A Real-World Cohort Study.
    Zhenhong Ren, Jianchao Lu
    Current oncology (Toronto, Ont.)Peer-reviewedCC BYFull textOncologyEurope PMC
  12. The Role of Long Non-Coding RNAs in Breast Cancer Diagnosis and Treatment Based on Evidence from Clinical Studies: A Scoping Review.
    Menelaos Zafrakas, Panayiota Papasozomenou, Ioannis Gavalas +2
    EpigenomesPeer-reviewedCC BYFull textOncologyEurope PMC
  13. Multimodal Immune Profile Score (IPS) as a Pan-Cancer Biomarker for Stratifying Outcomes of Immune Checkpoint Inhibitor Benefit in Microsatellite Stable Colorectal Cancer and Rare Solid Tumors
    M. A. Ting-Lin, E. S. Antonarakis, X. Wang +23
    medRxivPreprintPublic domainFull textOncologymedRxiv
  14. A spatial AI-based biomarker with independent prognostic value in early low- and intermediate- risk breast cancer
    C. Boissin, Y. Xiang, B. Liu +4
    medRxivPreprintCC BYFull textOncologymedRxiv
  15. Dual trajectories of post-traumatic growth and mental health in hysterectomy patients: a longitudinal study
    Yuqing Sun, Qinghua Guo, Yuanxiu Chen +6
    Frontiers in Public HealthPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  16. Feasibility of exercise training to address corticosteroid-induced changes in adolescents aged 10+ with lymphoma or leukemia during the first eight weeks of treatment: a pilot study.
    Vera Blümer, Sarah Erhard, Nicola Schanda +2
    Frontiers in pediatricsPeer-reviewedCC BYFull textOncologyEurope PMC
  17. Pan-cancer biomarkers of immune therapy resistance: mechanisms and clinical translation.
    Chao Wang, Dong Yang
    Frontiers in cell and developmental biologyPeer-reviewedCC BYFull textOncologyEurope PMC
  18. Interaction between severe postoperative complications and adjuvant chemotherapy on overall survival after upfront resection of pancreatic ductal adenocarcinoma.
    Shiwei Wu, Daobin Wang, Dongxing Zhang +5
    Frontiers in medicinePeer-reviewedCC BYFull textOncologyEurope PMC
  19. The genotoxic burden of toxic metals: bridging molecular mechanisms, biomonitoring, and multidisciplinary interventions.
    Sameera Reem Imthiaz, Suryapratap Ray, Gracy Anu Francis +1
    Frontiers in toxicologyPeer-reviewedCC BYFull textOncologyEurope PMC
  20. Mapping programmable mRNA research relevant to cancer-associated immune escape: a dual-database bibliometric and topic modeling analysis
    Xiao-Jie Zhou, Jun-Chi Zhu, Jian Dong +10
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  21. Knowledge, willingness, and reported prior prostate cancer testing among men in Palestine: a cross-sectional online survey
    Karam Salama, Islam Staiti, Moath Hammad +13
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  22. Low CT-derived vertebral attenuation as a prognostic factor in hepatocellular carcinoma patients treated with immune checkpoint inhibitors
    Shanshan Jiang, Yi Ren, Yuyang Wang +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  23. Manual lymphatic drainage reduces tissue sodium and self-reported pain in women with lipedema: a quantitative MRI study.
    E Nöll, A Henkel, M E Cornely +6
    Frontiers in cell and developmental biologyPeer-reviewedCC BYFull textOncologyEurope PMC
  24. Early-onset digestive system cancers attributable to the GBD composite dietary risk in China, 1990-2023: burden, trends, and projections.
    Ping Li, Xiao Tong
    Frontiers in medicinePeer-reviewedCC BYFull textOncologyEurope PMC
  25. miR-378f targets CAB39 to regulate autophagy in chemotherapy-induced peripheral neuropathy.
    Yeeun Kim, Myeongguk Jeong, Hyeokjin Kwon +5
    Frontiers in molecular neurosciencePeer-reviewedCC BYFull textOncologyEurope PMC